+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID03978377

Study of Heart and Lung Side Effects After Radiotherapy for Lung and Oesophageal Cancer

Led by University Medical Center Groningen · Updated on 2025-03-25

320

Participants Needed

3

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the potential cardiopulmonary side effects of thoracic radiotherapy in patients with oesophageal cancer and non-small cell lung cancer. The study aims to determine if pulmonary hypertension PH, particularly the pulmonary arterial hypertension subtype, is a clinically relevant radiation-induced side effect affecting survival and quality of life. This observational study seeks to clarify how radiation dose to the heart and lungs may contribute to treatment-related mortality, which is currently underrecognized. The study will assess changes in heart and lung function over time using diagnostic methods such as echocardiography, cardiac MRI, and blood biomarkers. Patients scheduled for curative external-beam radiotherapy will be monitored to track the incidence and progression of PH and other cardiovascular changes in relation to radiation dose. The research will also explore risk factors and the clinical impact of PH by correlating findings with patient-reported outcomes and survival. Participants will undergo regular assessments including imaging scans, blood tests, and quality of life questionnaires over at least one year. Researchers will measure the number of patients at high and intermediate risk for pulmonary hypertension, changes in cardiac biomarkers, and the incidence of other late cardiopulmonary toxicities. This comprehensive monitoring will help identify radiation-induced cardiovascular damage and inform future prevention and treatment strategies. The study is sponsored by University Medical Center Groningen and started in 2018 with an expected completion in 2027.

CONDITIONS

Brief Title

Cardiopulmonary Toxicity of Thoracic Radiotherapy

Research Team

C

CT Muijs, MD PhD

P

P van Luijk, DR

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here